Related Experiment Video
Updated: Jul 14, 2026
08:34
Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay
Published on: July 15, 2025
Molecular alterations during insulinoma tumorigenesis.
Y M H Jonkers1, F C S Ramaekers, E J M Speel
1Department of Molecular Cell Biology (box 17), Research Institute Growth and Development (GROW), University of Maastricht, P.O. Box 616, 6200 MD Maastricht, The Netherlands. Y.Jonkers@MOLCELB.unimaas.nl
Biochimica Et Biophysica Acta
|June 19, 2007
Summary
Insulinomas, common pancreatic tumors causing hypoglycemia, lack clear causes and diagnostic markers. Research is advancing understanding of their molecular basis for better diagnosis and treatment.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Insulinomas are the most frequent functioning endocrine pancreatic tumors causing hypoglycemia due to excess insulin secretion.
- The etiology of insulinomas is largely unknown, with only some cases linked to MEN1 gene mutations.
- Current diagnostic methods cannot reliably distinguish between benign and malignant insulinomas, complicating treatment decisions.
Purpose of the Study:
- To review recent advancements in understanding insulinoma development and progression.
- To highlight the need for improved molecular insights for better diagnosis, prognosis, and therapy.
- To summarize clinical detection, classification, and treatment strategies for insulinomas.
Main Methods:
- Review of molecular and genetic studies on insulinoma development.
- Analysis of primary tumors, transgenic mouse models, and cell lines.
- Investigation of MEN1 gene interactors and chromosomal abnormalities.
Main Results:
- Identification of numerous MEN1 gene product (menin) interactors.
- Discovery of recurrent chromosomal abnormalities suggesting candidate genes.
- Progress in understanding molecular pathways in insulinoma tumorigenesis.
Conclusions:
- Advances in research provide a better understanding of insulinoma molecular pathways.
- These findings are expected to lead to novel therapeutic targets and improved diagnostic/prognostic markers.
- Further research is crucial for improving clinical management of insulinomas.
Related Concept Videos
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:05Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...